Biggest News Aggregation in the World
📰 Exp Med News

Page 2 - Exp Med News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Exp Med. Real-time updates on events, politics, business and more.

Regulatory mechanisms of lncRNAs in cancer glycolysis

163 are also involved in resistance to cisplatin, temozolomide and 5-fluorouracil via altering glycolysis in gastric cancer, glioblastoma and CRC, respectively. Interestingly, Fu et al reported that lncRNA plasmacytoma variant translocation 1 (PVT1) maintains Myc expression in Sjögren’s syndrome. This expression regulates proliferation and immune effects of CD4 + T cells by controlling glycolytic metabolism. 164 Investigating the role of the PVT1-T cell glycolysis axis in tumor models may pr...
Gong Long Hali Long Cao Long Chen Long Asong Long South Korea

Short-term and long-term immune health ingredients | Natural Products INSIDER

When it comes to immune health, it is essential for brand owners to determine what type of immune support they’re trying to provide through a formulation. Examples include: a. A person thinks they may be coming down with a cold or flu—they need something to stimulate immune response. b. A person has a chronic immune weakness such as allergies, colds, flu, etc. —they need something for long-term support of immune functionality. c. A person has an autoimmune or overactive immune response—...
David Foreman Camargo Jr J Clin Nutr Nutrition Examination Survey Pillars Of Health University Of South Carolina College Pharmacy

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

What's the difference between HeLa and HeLa S3 cells? Part III: Theodore "Ted" Puck, PhD, and the first clonal isolation of human tumor cells

By terrasig on March 16, 2010. This post is the third in a series on the origin and history of HeLa S3 cells. The first post details how I came about to ask this question when launching my independent research laboratory. The second post details the life and careers of the legendary physician-scientist pioneer, Dr. Florence Rena Sabin. Today, we take up a discussion where we will finally learn the origin of HeLa S3 cells, complete with original literature citations. A recap W...
United States University Of Chicago Rockefeller University New York University Of Minnesota Fisher Jexpmed

COMMENTARY: From hope to reality: The promise of the Influenza Vaccines R&D Roadmap

SteveAllenPhoto / iStock Note: The views expressed in this commentary reflect the opinions of the authors and do not necessarily represent the policies or official positions of their organizations. Since the COVID-19 pandemic began roughly a year ago, public health officials have recorded more than 2 million deaths and almost 100 million infections from the SARS-CoV-2 virus, with the actual number likely substantially higher. Healthcare systems have been overwhelmed with caring for those suffer...
District Of Columbia United States Max Theiler Mary Lasker Foundation International Monetary Fund Aspen Institute
Source: umn.edu

Precigen Provides Pipeline Updates at the 39th Annual J.P. Morgan Healthcare Conference

Share this article Share this article GERMANTOWN, Md., Jan. 13, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today presented clinical and preclinical updates at the 39th Annual J.P. Morgan Healthcare Conference.  Helen Sabzevari, PhD, President and CEO of Precigen, presented a summary of 2020 clinical achievements and set forth Precigens clinical goals fo...
United States Precigenjp Morgan Steven Harasym Precigen Ultravector Helen Sabzevari Development Agreement

Novartis investigational oral therapy iptacopan (LNP023) receives FDA Breakthrough Therapy Designation for PNH and Rare Pediatric Disease Designation for C3G

Posted December 16th, 2020 for Novartis Paroxysmal nocturnal hemoglobinuria (PNH) is a rare and life-threatening blood disorder, resulting in debilitating symptoms that can impact patients’ quality of life 1–3 C3 glomerulopathy (C3G) is a rare renal disease, affecting young patients with a poor prognosis and significant unmet need 4-5 With potential to be the first oral treatment for a range of complement-driven diseases, complement factor B inhibitor iptacopan targets the underlying...
United States Eric Althoff Isabella Zinck Samir Shah Thomas Hungerbuehler Phil Mcnamara

Pandemic meets epidemic: COVID-19 and neurodegenerative diseases

Science Communication Opinion Share Post In this opinion piece, Andrei Surguchov, Professor of Neurology at University of Kansas Medical Center and Chief Editor of Biochemistry Research International, reflects on the impact the COVID-19 has had on the epidemic of neurodegenerative diseases and dementia. Lack of an active treatment strategy and vaccine makes SARS-CoV-2 infection an immense threat to humankind. The COVID-19 pandemic arrived when the world was already facing other rising health pr...
Surguchova Parkinson Turskil Ah Elizondog Biochem Pharmacol Glaucoma Foundation International Review Of Cell Molecular Biology A Community

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science